16:0-22:6 PA

产品名称：

474943-28-7
16:0-22:6 PA
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphate (sodium salt); PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); 110617

产品介绍：

产品说明

一般描述

16:0-22:6 PA or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphate (sodium) is a sodium salt of phosphatidic acid, with substitution of palmitic acid and docosahexaenic acid at the sn-1 and sn-2 positions respectively, in the glycerol backbone.

应用

16:0-22:6 PA or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphate (sodium salt) has been used as a calibration standard for lipidomic analysis.

包装

5 mL Clear Glass Sealed Ampule (840860C-25mg)

基本信息

经验(实验)分子式	C₄₁H₆₈O₈PNa
分子量	742.94

产品性质

测定	>99% (TLC)
包装	pkg of 1 × 2.5 mL (840860C-25mg)
manufacturer/tradename	Avanti Polar Lipids 840860C
浓度	10 mg/mL (840860C-25mg)
运输	dry ice
储存温度	−20℃
SMILES string	[H][C@@](COP([O-])(O)=O)(OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]

安全信息

象形图
警示用语：	Danger
危险声明	H302 - H315 - H319 - H331 - H336 - H351 - H361d - H372 - H412
预防措施声明	P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
危险分类	Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
靶器官	Central nervous system
储存分类代码	6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK	WGK 3
闪点(F)	does not flash
闪点(C)	does not flash